These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16300369)

  • 1. What ails health stocks?
    Birger J
    Fortune; 2005 Nov; 152(10):219-20, 223-4. PubMed ID: 16300369
    [No Abstract]   [Full Text] [Related]  

  • 2. Extensive consolidations continue in drug industry.
    Scott L
    Mod Healthc; 1994 Sep; 24(36):12. PubMed ID: 10136392
    [No Abstract]   [Full Text] [Related]  

  • 3. Bargain healthcare stocks worth buying.
    Murray D
    Med Econ; 2004 Aug; 81(15):25-6, 28-9. PubMed ID: 15453208
    [No Abstract]   [Full Text] [Related]  

  • 4. American Home bids $8.5 billion to buy New Jersey drug company.
    Scott L
    Mod Healthc; 1994 Aug; 24(32):12. PubMed ID: 10135368
    [No Abstract]   [Full Text] [Related]  

  • 5. Health stocks that should escape Hillary's scalpel.
    Neumeier S
    Fortune; 1993 Aug; 128(3):27-8. PubMed ID: 10127254
    [No Abstract]   [Full Text] [Related]  

  • 6. Centacor stock dips again after articles on Centoxin.
    Wagner M
    Mod Healthc; 1992 Apr; 22(17):20. PubMed ID: 10117574
    [No Abstract]   [Full Text] [Related]  

  • 7. The biotechnology industry: What's next?
    Guertin PA
    Biotechnol J; 2009 Aug; 4(8):1124-31. PubMed ID: 19685466
    [No Abstract]   [Full Text] [Related]  

  • 8. Antivirals--an increasingly healthy investment.
    McCarthy B
    Nat Biotechnol; 2007 Dec; 25(12):1390-3. PubMed ID: 18066033
    [No Abstract]   [Full Text] [Related]  

  • 9. Any diamonds in the diagnostic coal?
    Jacobs T
    Nat Biotechnol; 2006 Aug; 24(8):930. PubMed ID: 16900133
    [No Abstract]   [Full Text] [Related]  

  • 10. Investors explore buying technology data.
    Morrissey J
    Mod Healthc; 1996 Jan; 26(3):19. PubMed ID: 10153971
    [No Abstract]   [Full Text] [Related]  

  • 11. A change in the market--investing in diagnostics.
    Batchelder K; Miller P
    Nat Biotechnol; 2006 Aug; 24(8):922-6. PubMed ID: 16900131
    [No Abstract]   [Full Text] [Related]  

  • 12. Nursing home stocks star as other healthcare stocks lose their glitter.
    Punch L
    Mod Healthc; 1984 Dec; 14(16):116-8. PubMed ID: 10269169
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug firms' woes may slow profit growth.
    Dine DD
    Mod Healthc; 1989 Feb; 19(7):52. PubMed ID: 10291927
    [No Abstract]   [Full Text] [Related]  

  • 14. Ways to beat the drug bust. Pharma stocks are down for good reasons, but that doesn't mean they're all bad bets.
    Simons J
    Fortune; 2004 Nov; 150(10):230. PubMed ID: 15554088
    [No Abstract]   [Full Text] [Related]  

  • 15. Post-reform healthcare stocks to resemble utilities--analyst.
    Mod Healthc; 1993 Aug; 23(34):36. PubMed ID: 10127811
    [No Abstract]   [Full Text] [Related]  

  • 16. Merck's man in the hot seat.
    Simons J
    Fortune; 2004 Feb; 149(4):111-2, 114. PubMed ID: 14983668
    [No Abstract]   [Full Text] [Related]  

  • 17. Early-stage returns?
    Booth BL
    Nat Biotechnol; 2006 Nov; 24(11):1335-40. PubMed ID: 17093473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth in R&D investment holding up.
    Chipman A
    Nature; 2009 Nov; 462(7271):264. PubMed ID: 19924181
    [No Abstract]   [Full Text] [Related]  

  • 19. Silent running: the race to the clinic.
    Nature; 2006 Aug; 442(7103):614-5. PubMed ID: 16900171
    [No Abstract]   [Full Text] [Related]  

  • 20. Little biotech on the prairie.
    Wolfson W
    Chem Biol; 2007 Sep; 14(9):969-71. PubMed ID: 17884626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.